UIS
Comprehensive Support for Quality Clinical Research

Pharmaceutical and biotechnology companies face numerous challenges when conducting clinical research in emerging countries. Therefore, they seek qualified personnel who can meet recruitment goals while adhering to international standards.

Introducing Unidad de Investigación en Salud (UIS), a company dedicated to addressing the specific needs of clients seeking to develop clinical research protocols in Mexico. UIS has extensive experience in medicine testing and has conducted studies across all clinical phases.
UIS caters to clients with diverse profiles and needs, serving both large multinational pharmaceutical companies and small innovative enterprises worldwide. To achieve this, UIS utilizes a methodology based on its Total Quality Management System (QUIS). This system enables the standardization of processes and drives continuous improvement in crucial trial tasks. By implementing QUIS, UIS consistently focuses on delivering high-quality results while promoting efficiency throughout the trial processes.

“We provide comprehensive support for clinical research because, in addition to operating clinical sites, we also offer consulting services, project management, institutional review board (IRB), auditing, and monitoring. We are also pioneers in developing technologies for project control and training in the country,” says Dr. Merced Velázquez, CEO of the Health Research Unit.

With clinical sites in four Mexican cities, UIS covers all medical specialties and therapeutic categories. These sites, known for their high recruitment rates, are equipped with consulting rooms, laboratories, pharmacies, and clinical areas. In addition to implementing QUIS, the company conducts regular internal audits to ensure that the operations of each site comply with all relevant regulations. Furthermore, the quality assurance program oversees the care processes for the subjects involved in each investigation, as well as the integrity and quality of the data obtained.

Dr. Velázquez references the success story of a recent vaccine trial as an example of UIS achievements, which had a recruitment goal 20 times higher than its usual projects. To address this need, UIS dispatched recruiters to indigenous communities and marginalized colonies that are typically excluded from official vaccination programs. It also trained its staff and made adaptations to meet the required ethical and legal informed consent requirements. UIS aligned the specifications of the indigenous community’s internal government, the state government, and translators to acquire the necessary permits within 24 hours.

In other cases, UIS has successfully undertaken projects in highly specialized diseases involving individuals with disabilities, necessitating special facility adaptations. The company also implements communication strategies to minimize participant dropout rates in studies.

The unprecedented success of UIS can be attributed to various factors, including continuous staff training, the implementation of quality strategies, and the innovative business model, whereby a specialized team is integrated and trained for each project. Utilizing cutting-edge technology, UIS is prepared to assist its clients in successfully navigating the complex space of clinical trials.

Considering innovation as the core of its systematic approach, UIS continues to deliver quality work to its clients in the pharma and life sciences domains.